Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Eisai Bags FDA Approval For Aricept
Eisai said that Aricept 23mg tablet offers dosing option for patients with moderate-to-severe AD for whom few treatments are available. Aricept 23mg tablet has received approval based on
Eisai said that Aricept 23mg tablet offers dosing option for patients with moderate-to-severe AD for whom few treatments are available. Aricept 23mg tablet has received approval based on
Revenue of the specialty chemicals booked double-digit revenue growth of 14%, mainly driven by higher volumes. EBITDA for the second quarter was EUR614m, 21% higher than in 2009,
Beckman’s clinical diagnostics revenues increased 21.5% in constant currency in the second quarter, due to Olympus and growth in Asia Pacific. The company has also posted operating income
Takepron is a proton pump inhibitor discovered by Takeda Pharmaceutical and has been launched since 1992 in Japan. Takeda Pharmaceutical said that administration of low-dose aspirin for a
As per the terms of the agreement NovImmune is expected to get an upfront payment and is eligible to receive clinical milestones and royalties on sales. NovImmune said
The anti-PTH antibody forms the basis of an existing relationship between AbD Serotec and a diagnostic company which markets clinical parathyroid hormone assays. PTH is the regulator of
Emisphere said that an independent Data Monitoring Committee (DMC) conducted a futility analysis of one-year data for all patients enrolled in this two-year study, including assessments of safety
Cerenis and Novasep claimed that CER-001 represents a new approach in the fight against atherosclerotic cardiovascular disease and has shown preclinical efficacy in promoting reverse lipid transport. The
Cellceutix said that KM-133 is also an attractive compound as it may be eligible for an abridged FDA approval process that would allow the compound to go directly
Illumina claimed that the kit, which the company has commenced shipping broadly, is the first in a series of new kits that further advance data quality, ease of